ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Weekly Digest

No Analyst Rating Changes This Week

By ORTEX News · Edited by , Editor, ORTEX News1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The analyst data feed returned no published rating changes, upgrades, downgrades, or initiations for the week of 8 June 2026. The data source for analyst pulses is either offline or no activity was recorded for this period. No rating changes are presented here to avoid fabricating information.

Sector Themes

Despite the absence of analyst rating data, the ORTEX pulse feed recorded significant activity this week across 769 signals — covering short interest, options, utilisation, and cost-to-borrow data.

Broad Market Breadth

Activity spanned a wide range of tickers. Names such as TSLA, MSFT, AAPL, NVTS, and LLY appeared in the pulse feed. Coverage extended across US equities, ETFs, and international names including ASML, BIDU, SONY, and SHOP.

Short Interest and Utilisation in Focus

The dominant pulse types this week were short interest, utilisation, cost-to-borrow, and options. Speculative and high-short-interest names featured prominently. These included WOLF, LCID, IONQ, SPCE, and FCEL. Each has carried elevated short positioning in recent sessions.

Options Activity Widespread

Options pulses covered a broad set of names. SQQQ, TQQQ, SOXL, and NVDL — all leveraged ETFs — generated notable options signals. Single-stock activity was recorded in GS, JPM, PYPL, and SPOT.


Analyst rating data was unavailable for this digest. The content above reflects ORTEX pulse feed signals only. This is not investment advice.

Stocks in this article

How this article was generated

Generated
15 Jun 2026, 13:18
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.